Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy aTyr Pharma stock

Learn how to easily invest in aTyr Pharma stock.

aTyr Pharma Inc is a biotechnology business based in the US. aTyr Pharma shares (LIFE) are listed on the NASDAQ and all prices are listed in US Dollars. aTyr Pharma employs 49 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in aTyr Pharma

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – LIFE – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

aTyr Pharma stock price (NASDAQ: LIFE)

Use our graph to track the performance of LIFE stocks over time.

aTyr Pharma shares at a glance

Information last updated 2022-07-02.
Latest market close$2.85
52-week range$2.60 - $13.10
50-day moving average $3.23
200-day moving average $6.14
Wall St. target price$17.17
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-1.72

Buy aTyr Pharma shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 5 of 5
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
Finder Award
eToro
Stocks, ETFs, Cryptocurrency
$0
$10
$10
when you sign up and deposit $100
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, or TN.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.
SoFi Invest
Stocks, ETFs, Cryptocurrency
$0
$1
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
Tastyworks
Stocks, Options, ETFs, Cryptocurrency
$0
$0
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0
$0
$125 - $625
when you open and fund an account with $25,000 - $250,000+
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
Axos Bank Self Directed Investing
Stocks
$0
$1,000
$150
when you open an account and deposit at least $1500.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy aTyr Pharma stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

aTyr Pharma price performance over time

Historical closes compared with the close of $2.85 from 2022-07-01

1 week (2022-06-28) 1.42%
1 month (2022-06-01) 2.15%
3 months (2022-04-04) -49.20%
6 months (2022-01-03) -62.20%
1 year (2021-07-02) -41.12%
2 years (2020-07-02) -33.10%
3 years (2019-07-05) 5.0463
5 years (2017-07-03) 3.15

aTyr Pharma financials

Revenue TTM $2.1 million
Gross profit TTM $-23,264,000
Return on assets TTM -30.64%
Return on equity TTM -52.43%
Profit margin 0%
Book value $3.51
Market capitalisation $80 million

TTM: trailing 12 months

aTyr Pharma share dividends

We're not expecting aTyr Pharma to pay a dividend over the next 12 months.

Have aTyr Pharma's shares ever split?

aTyr Pharma's shares were split on a 1:14 basis on 30 June 2019. So if you had owned 14 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your aTyr Pharma shares – just the quantity. However, indirectly, the new 1300% higher share price could have impacted the market appetite for aTyr Pharma shares which in turn could have impacted aTyr Pharma's share price.

aTyr Pharma share price volatility

Over the last 12 months, aTyr Pharma's shares have ranged in value from as little as $2.6 up to $13.1. A popular way to gauge a stock's volatility is its "beta".

LIFE.US volatility(beta: 1.57)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while aTyr Pharma's is 1.569. This would suggest that aTyr Pharma's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

aTyr Pharma overview

aTyr Pharma, Inc. , a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. The company's lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase II clinical trial for pulmonary sarcoidosis; and in Phase 1b/2a clinical trial for treatment of other interstitial lung diseases (ILDs), such as chronic hypersensitivity pneumonitis and connective tissue disease related ILD. It is also developing ATYR2810, a fully humanized monoclonal antibody that is in preclinical development for the treatment of solid tumors. It has collaboration and license agreement with Kyorin Pharmaceutical Co. , Ltd. for the development and commercialization of efzofitimod for ILDs in Japan.

Frequently asked questions

What percentage of aTyr Pharma is owned by insiders or institutions?
Currently 3.03% of aTyr Pharma shares are held by insiders and 75.454% by institutions.
How many people work for aTyr Pharma?
Latest data suggests 49 work at aTyr Pharma.
When does the fiscal year end for aTyr Pharma?
aTyr Pharma's fiscal year ends in December.
Where is aTyr Pharma based?
aTyr Pharma's address is: 3545 John Hopkins Court, San Diego, CA, United States, 92121
What is aTyr Pharma's ISIN number?
aTyr Pharma's international securities identification number is: US0021202025
What is aTyr Pharma's CUSIP number?
aTyr Pharma's Committee on Uniform Securities Identification Procedures number is: 002120103

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site